Skip to main content
Journal cover image

Neuroprotection is associated with beta-adrenergic receptor antagonists during cardiac surgery: evidence from 2,575 patients.

Publication ,  Journal Article
Amory, DW; Grigore, A; Amory, JK; Gerhardt, MA; White, WD; Smith, PK; Schwinn, DA; Reves, JG; Newman, MF
Published in: J Cardiothorac Vasc Anesth
June 2002

OBJECTIVE: To determine the impact of perioperative beta-adrenergic receptor (betaAR) antagonist administration on neurologic complications. DESIGN: Observational database analysis. SETTING: A clinical investigation at a single tertiary academic medical center. PARTICIPANTS: Elective coronary artery bypass graft surgical patients operated on in the period 1994-1996. INTERVENTIONS: Patients were divided into 2 groups: (1) patients given betaAR antagonist-blocking drugs in the perioperative period, including during operation, and (2) patients not given betaAR antagonists. MEASUREMENTS AND MAIN RESULTS: betaAR antagonist use in 2,575 consecutive patients undergoing coronary artery bypass graft surgery (1994-1996) was determined using the Cardiovascular Database and Anesthesia Information System Database. Outcome variables were postoperative stroke, coma, and transient ischemic attack. Of patients, 113 (4.4%) had postoperative neurologic complications, including stroke (n = 44), coma (n = 12), and transient ischemic attack (n = 3). Of patients, 2,296 (89%) received perioperative betaAR antagonist therapy, and 279 (11%) did not. Adverse neurologic events occurred in 3.9% (n = 90) of patients who received perioperative betaAR antagonists and 8.2% (n = 23) of patients who did not receive betaAR antagonists (odds ratio, 0.45; 95% confidence interval, 0.28 to 0.73; p = 0.003, unadjusted.) Severe neurologic outcomes (stroke and coma) occurred in 1.9% (n = 44) of patients who received betaAR antagonists and 4.3% (n = 12) of patients who did not receive betaAR antagonists (odds ratio, 0.43; 95% confidence interval, 0.23 to 0.83; p = 0.016). CONCLUSION: Use of beta-adrenergic antagonists was associated with a substantial reduction in the incidence of postoperative neurologic complications. A prospective randomized trial is needed to verify this potentially important neuroprotective strategy in cardiac surgery.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Cardiothorac Vasc Anesth

DOI

ISSN

1053-0770

Publication Date

June 2002

Volume

16

Issue

3

Start / End Page

270 / 277

Location

United States

Related Subject Headings

  • Stroke
  • Retrospective Studies
  • Preoperative Care
  • Postoperative Complications
  • Neuroprotective Agents
  • Middle Aged
  • Male
  • Ischemic Attack, Transient
  • Intraoperative Care
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Amory, D. W., Grigore, A., Amory, J. K., Gerhardt, M. A., White, W. D., Smith, P. K., … Newman, M. F. (2002). Neuroprotection is associated with beta-adrenergic receptor antagonists during cardiac surgery: evidence from 2,575 patients. J Cardiothorac Vasc Anesth, 16(3), 270–277. https://doi.org/10.1053/jcan.2002.124132
Amory, David W., Alina Grigore, John K. Amory, Mark A. Gerhardt, William D. White, Peter K. Smith, Debra A. Schwinn, J. G. Reves, and Mark F. Newman. “Neuroprotection is associated with beta-adrenergic receptor antagonists during cardiac surgery: evidence from 2,575 patients.J Cardiothorac Vasc Anesth 16, no. 3 (June 2002): 270–77. https://doi.org/10.1053/jcan.2002.124132.
Amory DW, Grigore A, Amory JK, Gerhardt MA, White WD, Smith PK, et al. Neuroprotection is associated with beta-adrenergic receptor antagonists during cardiac surgery: evidence from 2,575 patients. J Cardiothorac Vasc Anesth. 2002 Jun;16(3):270–7.
Amory, David W., et al. “Neuroprotection is associated with beta-adrenergic receptor antagonists during cardiac surgery: evidence from 2,575 patients.J Cardiothorac Vasc Anesth, vol. 16, no. 3, June 2002, pp. 270–77. Pubmed, doi:10.1053/jcan.2002.124132.
Amory DW, Grigore A, Amory JK, Gerhardt MA, White WD, Smith PK, Schwinn DA, Reves JG, Newman MF. Neuroprotection is associated with beta-adrenergic receptor antagonists during cardiac surgery: evidence from 2,575 patients. J Cardiothorac Vasc Anesth. 2002 Jun;16(3):270–277.
Journal cover image

Published In

J Cardiothorac Vasc Anesth

DOI

ISSN

1053-0770

Publication Date

June 2002

Volume

16

Issue

3

Start / End Page

270 / 277

Location

United States

Related Subject Headings

  • Stroke
  • Retrospective Studies
  • Preoperative Care
  • Postoperative Complications
  • Neuroprotective Agents
  • Middle Aged
  • Male
  • Ischemic Attack, Transient
  • Intraoperative Care
  • Humans